|
1
|
A range of cancers is associated with the rs6983267 marker on chromosome 8.
|
Cancer Res
|
2008
|
2.43
|
|
2
|
The NOD2 3020insC mutation and the risk of colorectal cancer.
|
Cancer Res
|
2004
|
2.01
|
|
3
|
A high proportion of founder BRCA1 mutations in Polish breast cancer families.
|
Int J Cancer
|
2004
|
1.96
|
|
4
|
A novel founder CHEK2 mutation is associated with increased prostate cancer risk.
|
Cancer Res
|
2004
|
1.60
|
|
5
|
Germline 657del5 mutation in the NBS1 gene in breast cancer patients.
|
Int J Cancer
|
2003
|
1.13
|
|
6
|
The 3020insC Allele of NOD2 Predisposes to Cancers of Multiple Organs.
|
Hered Cancer Clin Pract
|
2005
|
1.04
|
|
7
|
Breast cancer risk reduction associated with the RAD51 polymorphism among carriers of the BRCA1 5382insC mutation in Poland.
|
Cancer Epidemiol Biomarkers Prev
|
2003
|
0.99
|
|
8
|
CDKN2A common variant and multi-organ cancer risk--a population-based study.
|
Int J Cancer
|
2006
|
0.99
|
|
9
|
Germline 657del5 mutation in the NBS1 gene in patients with malignant melanoma of the skin.
|
Melanoma Res
|
2003
|
0.83
|
|
10
|
Cancer Familial Aggregation (CFA) and G446A polymorphism in ARLTS1 gene.
|
Breast Cancer Res Treat
|
2006
|
0.81
|
|
11
|
A simple method of investigating mutations in CHEK2 by DHPLC: a study of the German populations of Saxony, Saxony-Anhalt, and Thuringia.
|
Cancer Genet Cytogenet
|
2010
|
0.80
|
|
12
|
Low-risk Genes and Multi-organ Cancer Risk in the Polish Population.
|
Hered Cancer Clin Pract
|
2006
|
0.78
|
|
13
|
Evaluation of IP-RP-HPLC for length determination of the trinucleotide repeat fragments in Huntington's disease.
|
J Chromatogr Sci
|
2010
|
0.75
|
|
14
|
[Terminology concerning intravenous ports].
|
Wiad Lek
|
2015
|
0.75
|
|
15
|
New analysis method of myotonic dystrophy 1 based on quantitative fluorescent polymerase chain reaction.
|
Genet Test Mol Biomarkers
|
2009
|
0.75
|